This research contradicts previous concerns about the potential of drugs like Ozempic to trigger suicidal ideation and ...

Researchers find that Semaglutide improves cognitive function and reduces amyloid and tau pathology in Alzheimer's disease ...

Semaglutide use was associated with a lower risk for opioid overdose than other antidiabetic medications in comorbid type 2 diabetes and OUD.

Semaglutide significantly reduces cardiovascular events and adverse effects in overweight and obese patients. The study ...

Participants with type 2 diabetes who stopped insulin after receiving the novel ReCET endoscopic procedure in combination ...

Rapper Fat Joe— who at his heaviest was 470 lbs. — said he watches his portions, thanks to a little help from Ozempic ...

Chinese insulin maker Gan & Lee Pharmaceuticals is wading into the obesity world with an injectable GLP-1 agonist that beat Novo Nordisk's Ozempic (semaglutide) at lowering glycated hemoglobin (HbA1c) ...

In response to rising demand for weight loss medications, WeightWatchers has launched a low-cost alternative to ...

Health secretary Wes Streeting announced weight loss injections could be used to get people living with obesity "back to work ...

Discover a new treatment approach for Type 2 diabetes that could dramatically reduce, or even eliminate, the need for insulin ...

Obesity treatment should start at a young age, he said, because if you have overweight at ages 3-6 years, the likelihood of ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...